{"organizations": [], "uuid": "94d16376d52915323d96abc9c5d43d618d4da2bc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180429.html", "section_title": "Archive News &amp; Video for Sunday, 29 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-benitec-biopharma-launches-entitle/brief-benitec-biopharma-launches-entitlement-offer-and-placement-idUSFWN1S605Q", "country": "US", "domain_rank": 408, "title": "BRIEF-Benitec Biopharma Launches Entitlement Offer And Placement", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.899, "site_type": "news", "published": "2018-04-30T09:19:00.000+03:00", "replies_count": 0, "uuid": "94d16376d52915323d96abc9c5d43d618d4da2bc"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-benitec-biopharma-launches-entitle/brief-benitec-biopharma-launches-entitlement-offer-and-placement-idUSFWN1S605Q", "ord_in_thread": 0, "title": "BRIEF-Benitec Biopharma Launches Entitlement Offer And Placement", "locations": [], "entities": {"persons": [], "locations": [{"name": "highbridge", "sentiment": "none"}], "organizations": [{"name": "brief-benitec biopharma launches entitlement", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "benitec biopharma ltd", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 30 (Reuters) - Benitec Biopharma Ltd:\n* LAUNCHED ENTITLEMENT OFFER TO ELIGIBLE SHAREHOLDERS AND INSTITUTIONAL PLACEMENT TO HIGHBRIDGE CAPITAL MANAGEMENT LLC\n* WILL ISSUE 772,201 AMERICAN DEPOSITARY SHARES (ADS) TO HIGHBRIDGE; ISSUE PRICE UNDER PLACEMENT US$2.59 PER ADS\n* 1 FOR 2 PRO RATA RENOUNCEABLE ENTITLEMENT OFFER TO ELIGIBLE SHAREHOLDERS AT AUD 17 CENTS Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-30T09:19:00.000+03:00", "crawled": "2018-04-30T13:18:36.000+03:00", "highlightTitle": ""}